Pascal Chastagner

5.5k total citations
161 papers, 3.5k citations indexed

About

Pascal Chastagner is a scholar working on Molecular Biology, Genetics and Neurology. According to data from OpenAlex, Pascal Chastagner has authored 161 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 49 papers in Genetics and 49 papers in Neurology. Recurrent topics in Pascal Chastagner's work include Glioma Diagnosis and Treatment (47 papers), Neuroblastoma Research and Treatments (47 papers) and Childhood Cancer Survivors' Quality of Life (34 papers). Pascal Chastagner is often cited by papers focused on Glioma Diagnosis and Treatment (47 papers), Neuroblastoma Research and Treatments (47 papers) and Childhood Cancer Survivors' Quality of Life (34 papers). Pascal Chastagner collaborates with scholars based in France, United States and United Kingdom. Pascal Chastagner's co-authors include François Doz, Dominique Plantaz, C Kalifa, Didier Frappaz, Olivier Hartmann, Jean Michon, Nicolas Sirvent, Éric Bouffet, H Rubie and Carole Coze and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Pascal Chastagner

155 papers receiving 3.4k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Pascal Chastagner 1.1k 1.1k 1.1k 809 634 161 3.5k
Paul M. Zeltzer 980 0.9× 1.2k 1.1× 1.9k 1.7× 591 0.7× 573 0.9× 64 3.8k
Dominique Plantaz 2.3k 2.0× 1.5k 1.4× 719 0.7× 703 0.9× 898 1.4× 173 4.7k
Andrew W. Walter 786 0.7× 825 0.8× 1.1k 1.1× 544 0.7× 354 0.6× 54 2.6k
Lingyun Ji 657 0.6× 828 0.8× 587 0.5× 371 0.5× 944 1.5× 130 3.5k
Franca Fossati‐Bellani 897 0.8× 766 0.7× 703 0.7× 767 0.9× 1.2k 1.9× 83 4.3k
Roberto Luksch 1.8k 1.5× 1.4k 1.3× 551 0.5× 516 0.6× 918 1.4× 189 4.5k
Daniel C. Bowers 1.0k 0.9× 954 0.9× 1.6k 1.5× 753 0.9× 310 0.5× 88 3.3k
M. Fatih Okcu 546 0.5× 817 0.8× 1.2k 1.1× 871 1.1× 723 1.1× 148 3.8k
Robert P. Castleberry 2.5k 2.2× 1.5k 1.4× 551 0.5× 664 0.8× 657 1.0× 75 4.6k
Stewart J. Kellie 1.0k 0.9× 1.2k 1.1× 1.9k 1.8× 365 0.5× 471 0.7× 76 3.5k

Countries citing papers authored by Pascal Chastagner

Since Specialization
Citations

This map shows the geographic impact of Pascal Chastagner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Chastagner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Chastagner more than expected).

Fields of papers citing papers by Pascal Chastagner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascal Chastagner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Chastagner. The network helps show where Pascal Chastagner may publish in the future.

Co-authorship network of co-authors of Pascal Chastagner

This figure shows the co-authorship network connecting the top 25 collaborators of Pascal Chastagner. A scholar is included among the top collaborators of Pascal Chastagner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pascal Chastagner. Pascal Chastagner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Auquier, Pascal, Virginie Gandemer, Yves Bertrand, et al.. (2024). Educational outcomes in siblings of childhood leukemia survivors: Factors associated with school difficulties and comparison with general population. Cancer Medicine. 13(3). e6821–e6821. 2 indexed citations
2.
Gauthier, Mélanie, David Moulin, Jean‐Baptiste Vincourt, et al.. (2024). Deciphering Natural Killer Cell Cytotoxicity Against Medulloblastoma in vitro and in vivo: Implications for Immunotherapy. ImmunoTargets and Therapy. Volume 13. 319–333. 1 indexed citations
3.
André, Nicolás, Marie‐Cécile Le Deley, Isabelle Aerts, et al.. (2024). METRO-PD1: Phase 1 study of nivolumab in combination with metronomic chemotherapy in children and adolescents with relapsing/refractory solid tumors. European Journal of Cancer. 198. 113525–113525. 5 indexed citations
4.
Auquier, Pascal, Yves Bertrand, Marie‐Dominique Tabone, et al.. (2023). Impact of childhood leukemia on siblings: their long-term perception of family functioning and its relationship with their psychosocial characteristics using structural equation modeling. Journal of Cancer Survivorship. 18(4). 1403–1415.
5.
Durand, Maxime, Jérôme Devy, Gautier Laurent, et al.. (2023). Radiosensitization with Gadolinium Chelate-Coated Gold Nanoparticles Prevents Aggressiveness and Invasiveness in Glioblastoma. International Journal of Nanomedicine. Volume 18. 243–261. 18 indexed citations
6.
Leblond, Pierre, Emmanuelle Tresch‐Bruneel, Caroline Solas, et al.. (2023). Phase I Study of a Combination of Fluvastatin and Celecoxib in Children with Relapsing/Refractory Low-Grade or High-Grade Glioma (FLUVABREX). Cancers. 15(7). 2020–2020. 5 indexed citations
7.
Leblond, Pierre, Franck Bourdeaut, Anne Pagnier, et al.. (2023). Retrospective National “Real Life” Experience of the SFCE with the Metronomic MEMMAT and MEMMAT-like Protocol. Journal of Clinical Medicine. 12(4). 1415–1415. 7 indexed citations
8.
Auquier, Pascal, Zeinab Hamidou, Yves Bertrand, et al.. (2022). Brothers and sisters of childhood acute leukemia survivors: Their long‐term quality of life and its determinants. Cancer Medicine. 12(5). 6200–6212. 4 indexed citations
9.
Würthwein, Gudrun, Claudia Lanvers‐Kaminsky, Nicolás André, et al.. (2020). Can we optimise doxorubicin treatment regimens for children with cancer? Pharmacokinetic simulations and a Delphi consensus procedure. BMC Pharmacology and Toxicology. 21(1). 37–37. 10 indexed citations
10.
Picard, Cécile, Cécile Faure‐Conter, Pierre Leblond, et al.. (2019). Exploring heterogeneity of adrenal cortical tumors in children: The French pediatric rare tumor group (Fracture) experience. Pediatric Blood & Cancer. 67(2). e28086–e28086. 13 indexed citations
11.
Pierron, Gaëlle, Paul Fréneaux, Sophie Huybrechts, et al.. (2017). NUT carcinoma in children and adults: A multicenter retrospective study. Pediatric Blood & Cancer. 64(12). 64 indexed citations
12.
Chastagner, Pascal. (2017). Nécessité d’une réflexion globale autour des thérapeutiques « personnalisées » proposées en oncologie pédiatrique. Archives de Pédiatrie. 24(6). 517–519. 1 indexed citations
13.
Chastagner, Pascal, et al.. (2014). Preclinical Studies of Pegylated- and Non-Pegylated Liposomal Forms of Doxorubicin as Radiosensitizer on Orthotopic High-Grade Glioma Xenografts. Pharmaceutical Research. 32(1). 158–166. 13 indexed citations
14.
Janoušková, Hana, David Y. Léger, Fanny Noulet, et al.. (2012). Integrin α5β1 Plays a Critical Role in Resistance to Temozolomide by Interfering with the p53 Pathway in High-Grade Glioma. Cancer Research. 72(14). 3463–3470. 104 indexed citations
15.
Kimmoun, Antoine, Audrey Contet, Laurence Clément, et al.. (2010). Successful management with clofarabine for refractory leukaemia in a young adult with chronic renal failure. American Journal of Hematology. 86(3). 321–323. 2 indexed citations
16.
Labussière, Marianne, Sophie Pinel, Marc Vandamme, François Plénat, & Pascal Chastagner. (2010). Radiosensitizing Properties of Bortezomib Depend on Therapeutic Schedule. International Journal of Radiation Oncology*Biology*Physics. 79(3). 892–900. 11 indexed citations
17.
Orbach, Daniel, Pascal Chastagner, & François Doz. (2008). [Cancer in children: epidemiologic, diagnostic and therapeutic characteristics].. PubMed. 58(5). 557–63.
18.
Vermeulen, Jessica, Steven Ballet, Odile Oberlin, et al.. (2006). Incidence and prognostic value of tumour cells detected by RT–PCR in peripheral blood stem cell collections from patients with Ewing tumour. British Journal of Cancer. 95(10). 1326–1333. 19 indexed citations
19.
Bernard, Frédéric, Caroline Thomas, Y. Bertrand, et al.. (2005). Multi-centre pilot study of 2-chlorodeoxyadenosine and cytosine arabinoside combined chemotherapy in refractory Langerhans cell histiocytosis with haematological dysfunction. European Journal of Cancer. 41(17). 2682–2689. 87 indexed citations
20.
Pérel, Yves, Dominique Valteau‐Couanet, Jean Michon, et al.. (2004). Le pronostic du neuroblastome de l'enfant. Méthodes d'étude et utilisation en pratique clinique. Archives de Pédiatrie. 11(7). 834–842. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul M. Zeltzer Breakdown of academic impact, for papers by Dominique Plantaz Breakdown of academic impact, for papers by Andrew W. Walter Breakdown of academic impact, for papers by Lingyun Ji Breakdown of academic impact, for papers by Franca Fossati‐Bellani Breakdown of academic impact, for papers by Roberto Luksch Breakdown of academic impact, for papers by Daniel C. Bowers Breakdown of academic impact, for papers by M. Fatih Okcu Breakdown of academic impact, for papers by Robert P. Castleberry Breakdown of academic impact, for papers by Stewart J. Kellie
Rankless by CCL
2026